Seattle Genetics reported $-73783000 in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -42.78M 23.1M
Agios Pharmaceuticals AGIO:US $ -88.87M 0.13M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
Amgen AMGN:US $ 3188M 218M
Astellas Pharma 4503:JP Y 53942M 59543M
Bayer BAYN:GR € 3035M 1119M
Biogen BIIB:US $ 991.8M 155.8M
Biomarin Pharmaceutical BMRN:US $ 41.16M 14.24M
Bluebird Bio BLUE:US $ -234.8M 9.32M
Bristol Myers Squibb BMY:US $ 5679M 455M
Celldex Therapeutics CLDX:US $ -12.68M 3.19M
Daiichi Sankyo 4568:JP Y 60453M 71607M
Eisai 4523:JP Y 64862M 61319M
Eli Lilly And LLY:US $ 1797.7M 218.8M
Esperion Therapeutics ESPR:US $ -32380000 50.29M
Exelixis EXEL:US $ 126.68M 128.06M
Gilead Sciences GILD:US $ 2816M 669M
GlaxoSmithKline GSK:LN 2626M 584M
Glaxosmithkline GSK:US $ 2626M 584M
Immunogen IMGN:US $ -26.83M 1.54M
Insmed INSM:US $ -84649000 4.74M
Karyopharm Therapeutics KPTI:US $ -48819000 3.32M
Macrogenics MGNX:US $ -37498000 11.07M
Mirati Therapeutics MRTX:US $ -163.78M 31.65M
Moderna Inc MRNA:US 3.13B 1.85B
Nektar Therapeutics NKTR:US $ -106.66M 0.81M
Novartis NOVN:VX SF 4772M 423M
Pfizer PFE:US $ 7593M 610M
Puma Biotechnology PBYI:US $ -13.7M 36.8M
Regeneron Pharmaceuticals REGN:US $ 3418.3M 2238.2M
Sarepta Therapeutics SRPT:US $ -159.13M 26.19M
Seattle Genetics SGEN:US $ -73.78M 33.35M
Spectrum Pharmaceuticals SPPI:US $ -44M 10.38M
Teva Pharmaceutical TEVA:IT 1.14B 34M
Vertex Pharmaceuticals VRTX:US $ -5.12M 917.88M
Xencor XNCR:US $ 10.84M 24.87M
YTE INCY:US $ 169.77M 41.12M